For media enquiries or more information about research at the Djavad Mowafaghian Centre for Brain Health, please contact Vanessa Hrvatin (Communications Coordinator) or Clement Woo (Communications Manager).

To keep in touch with the Centre and up-to-date on our research, follow us on Twitter or subscribe to Brain Matters, our monthly e-newsletter.

Online advice for preventing Alzheimer disease often problematic Sep 13, 2016

New research from the Djavad Mowafaghian Centre for Brain Health finds that many online resources for preventing Alzheimer’s disease are problematic and could be steering people in the wrong direction.

In a survey of online articles about preventing Alzheimer’s disease, Centre researchers found many websites offered poor advice and one in five promoted products for sale—a clear conflict of interest.

Researchers find mutation responsible for altered brain function linked to autism Sep 6, 2016

Mutations associated with autism that were previously thought to reduce excitatory synaptic transmissions are now shown to enhance those same transmissions, and result in autism-like behaviours in animal models, according to new research from Dr.

Snyder, Soma, Floresco, Winstanley, Galea
New labs moving into the Centre this fall Aug 30, 2016

This past year has been a year of incredible growth at the Djavad Mowafaghian Centre for Brain Health ("the Centre"), and over the next few months, we’ll be welcoming five new labs from the UBC Department of Psychology into Centre space. By bringing together experts from disciplines previously housed across the UBC campus and having them work in close proximity with one another within the Centre and in the Koerner labs, we look forward to seeing even more opportunities for knowledge exchange and collaboration.

We hope you'll join us in welcoming:

Scientist using Twitter on his mobile phone in the lab.
Illuminating optogenetics and the role of researchers on social media. Aug 29, 2016

Should scientists and science communicators use Twitter? That’s the question researchers at UBC’s National Core for Neuroethics and the Djavad Mowafaghian Centre for Brain Health answered by way of an investigation into the online conversation around optogenetics. Their paper, published today in Neuroethics, shines a light on the way academics are using social media to communciate their research.

THC makes rats lazy, less willing to try cognitively demanding tasks Aug 23, 2016

New research from Dr. Catharine Winstanley's lab, published today in the Journal of Psychiatry and Neuroscience, suggests there may be some truth to the belief that marijuana use causes laziness—at least in rats. 

The researchers discovered that tetrahydrocannabinol (THC), the main psychoactive ingredient in marijuana, makes rats less willing to try a cognitively demanding task.

Dr. Brian MacVicar in his lab
Centre members receive CIHR funding to further brain health research Aug 5, 2016

The Canadian Institutes for Health Research (CIHR) has announced its latest grants, and 14 members of the Djavad Mowafaghian Centre for Brain Health are among the awardees.

Brian MacVicar, Professor, Department of Psychiatry and Co-Director of the Centre received the largest grant in the Faculty of Medicine from CIHR’s latest round of awards, with a Foundation Grant of $3.3 million over seven years. Dr. MacVicar’s lab will explore neuron-glia interactions in brain disease.

CARD 2016 Alzheimer Update participant with iClicker
Patient collaboration in research leads to meaningful outcomes Jul 8, 2016

Dr. Julie Robillard believes that good research puts patients first. In the labs and clinics of the Djavad Mowafaghian Centre for Brain Health, she has been working hard to improve communication between researchers and the people who could most benefit from their work and to integrate patients into research from the beginning, at every stage from study design to communication of results.

Researchers tackle non-adherence to MS medication in new study Jul 6, 2016

For some patients with multiple sclerosis (MS), adhering to a strict disease-modifying therapy (DMT) regimen can be challenging. Some DMTs for the treatment of relapsing-remitting MS are injectable and require long-term use, so it’s understandable that some patients may not adhere well to these treatments. Kyla McKay, PhD candidate and epidemiology researcher with Dr. Helen Tremlett’s Pharmacoepidemiology in Multiple Sclerosis Research Group, set out to discover why.

Dr. Max Cynader appointed to CIHR College of Reviewers Jun 17, 2016

Dr. Max Cynader has been appointed to a Chair in the Canadian Institutes for Health Research (CIHR) College of Reviewers, a new program that will serve CIHR and its stakeholders by bringing together a diverse cohort of researchers to enhance the quality of the peer review process.